Status:

COMPLETED

Protein and Skeletal Muscle in Older Twins: Role of the Gut Microbiome

Lead Sponsor:

King's College London

Collaborating Sponsors:

Guy's and St Thomas' NHS Foundation Trust

Conditions:

Sarcopenia

Frailty

Eligibility:

All Genders

60-120 years

Phase:

NA

Brief Summary

Research Question: Does the gut microbiome contribute to muscle anabolic resistance to protein supplementation in older adults? Background: Loss of muscle occurs with age and skeletal muscle in older...

Detailed Description

Research Question: Does the gut microbiome contribute to muscle anabolic resistance to protein supplementation in older adults? Background: Loss of skeletal muscle mass and strength occurs with incre...

Eligibility Criteria

Inclusion

  • Aged \>=60 years
  • Dietary protein intake of \<1.3g/kg/day
  • Able to consent
  • Able to access video calls on a device such as laptop/tablet

Exclusion

  • Severe food allergy
  • Current or recent antibiotic use (preceding 3 months)
  • Currently or recent use of protein or leucine supplements (preceding 3 months)
  • Currently or recent use of probiotic or prebiotic food supplements (preceding 3 months)
  • Current or prior history of gastrointestinal disease e.g. gastrointestinal cancer, inflammatory bowel disease, bariatric surgery, irritable bowel syndrome
  • history of any significant injury or surgery which currently affects physical functioning and ability to undertake chair stand test
  • weight loss of ≥5% of body weight in preceding 6-12 months
  • Currently involved in other intervention studies
  • Any condition or circumstance likely to interfere with the normal conduct of the study and interpretation of the results, as judged by the investigators As the study population are over 60 years old, it is assumed that there will be no pregnant women who are eligible to take part.

Key Trial Info

Start Date :

April 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2021

Estimated Enrollment :

71 Patients enrolled

Trial Details

Trial ID

NCT04309292

Start Date

April 29 2021

End Date

December 20 2021

Last Update

October 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Twin Research and Genetics

London, United Kingdom